Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Finasteride reduced VEGF expression and microvascular density in diabetic mice.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

DA-9401 helps protect rat testis from finasteride damage.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Apremilast may help treat hair loss in alopecia areata.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Finasteride increases CD8+ T cells in BPH tissues.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.